Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration

PURPOSE: The study was undertaken for regulatory purposes to establish clinical biosimilarity and interchangeability of a ranibizumab biosimilar with reference product. PATIENTS AND METHODS: A total of 159 subjects with neovascular (wet) age-related macular degeneration (AMD) were dosed with ranibiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Apsangikar, Prasad, Ghadge, Pravin, Naik, Manoj, Nair, Santosh, Payghan, Ravikiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291850/
https://www.ncbi.nlm.nih.gov/pubmed/34295147
http://dx.doi.org/10.2147/OPTH.S307746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291850/
https://www.ncbi.nlm.nih.gov/pubmed/34295147
http://dx.doi.org/10.2147/OPTH.S307746

Ejemplares similares